Relation of the renin–angiotensin–aldosterone system with potential cardiac injury and remodelling: the SABPA study

References

• Tibazarwa KB, Damasceno AA. Hypertension in developing countries. Can J Cardiol. 2014;30:527–533.
   PubMed Web of Science ®Google Scholar
• Lloyd-Sherlock P, Beard J, Minicuci N, et al. Hypertension among older adults in low-and middle-income countries: prevalence, awareness and control. Int J Epidemiol. 2014;43:116–128.
   PubMed Web of Science ®Google Scholar
• Ferrario CM, Strawn WB. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol. 2006;98:121–128.
   PubMed Web of Science ®Google Scholar
• Ma T, Kam K, Yan B, et al. Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status. Br J Pharmacol. 2010;160:1273–1292.
   PubMed Web of Science ®Google Scholar
• Sato Y, Fujiwara H, Takatsu Y. Biochemical markers in heart failure. J Cardiol. 2012;59:1–7.
   PubMed Web of Science ®Google Scholar
• Azzam ZS, Kinaneh S, Bahouth F, et al. Involvement of cytokines in the pathogenesis of salt and water imbalance in congestive heart failure. Front Immunol. 2017;8:716.
   PubMed Web of Science ®Google Scholar
• Ferreira J, Santos M, Almeida S, et al. High-dose spironolactone changes renin and aldosterone levels in acutely decompensated heart failure. Cor Vasa. 2014;56:e463–e470.
   Google Scholar
• du Cailar G, Fesler P, Ribstein J, et al. Dietary sodium, aldosterone, and left ventricular mass changes during long-term inhibition of the renin-angiotensin system. Hypertension. 2010;56:865–870.
   PubMed Web of Science ®Google Scholar
• Lindhorst J, Alexander N, Blignaut J, et al. Differences in hypertension between blacks and whites: an overview. Cardiovasc J Afr. 2007;18:241–247.
   PubMedGoogle Scholar
• Schutte AE, Botha S, Fourie CMT, et al. Recent advances in understanding hypertension development in sub-Saharan Africa. J Hum Hypertens. 2017;31:491–500.
   PubMed Web of Science ®Google Scholar
• Myburg CE, Malan L, Wentzel A, et al. Coping and cardiac troponin T-A risk for hypertension and sub-clinical ECG left ventricular hypertrophy: the SABPA study. Heart Lung Circ. 2019;28:908–916.
   PubMed Web of Science ®Google Scholar
• Sliwa K, Wilkinson D, Hansen C, et al. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet. 2008;371:915–922.
   PubMed Web of Science ®Google Scholar
• Braunwald E, Antmann EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non ST elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of unstable angina). Circulation. 2000;102:1193–1209.
   PubMed Web of Science ®Google Scholar
• Ozturk TC, Unluer E, Denizbasi A, et al. Can NT-proBNP be used as a criterion for heart failure hospitalization in emergency room? J Res Med Sci. 2011;16:1564–1571.
   PubMed Web of Science ®Google Scholar
• Takeda T, Kohno M. Brain natriuretic peptide in hypertension. Hypertens Res. 1995;18:259–266.
   PubMedGoogle Scholar
• Khan SQ, Dhillon OS, O’Brien RJ, et al. C-terminal proVasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction-The Leicester Acute Myocardial Infarction Peptide (LAMP) Study. Circulation. 2007;115:2103–2110.
   PubMed Web of Science ®Google Scholar
• Katan M, Morgenthaler N, Widmer I, et al. Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level. Neuro Endocrinol Lett. 2008;29:341–346.
   PubMed Web of Science ®Google Scholar
• Malan L, Hamer M, Frasure-Smith N, et al. Cohort profile: Sympathetic activity and Ambulatory Blood Pressure in Africans (SABPA) prospective cohort study. Int J Epidemiol. 2015; 44:1814–1822.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–612.
   PubMed Web of Science ®Google Scholar
• Seedat Y. Hypertension in black South Africans. J Hum Hypertens. 1999;13:96–103.
   PubMed Web of Science ®Google Scholar
• Tomaschitz A, Pilz S, Ritz E, et al. Associations of plasma renin with 10-year cardiovascular mortality, sudden cardiac death, and death due to heart failure. Eur Heart J. 2011;32:2642–2649.
   PubMed Web of Science ®Google Scholar
• Malan L, Hamer M, von KR, et al. Chronic defensiveness and neuroendocrine dysfunction reflect a novel cardiac troponin T cut point: the SABPA study. Psychoneuroendocrinology. 2017;85:20–27.
   PubMed Web of Science ®Google Scholar
• Hamer M, Malan L, Schutte AE, et al. Plasma renin responses to mental stress and carotid intima-media thickness in black Africans: the SABPA study. J Hum Hypertens. 2011;25:437–443.
   PubMed Web of Science ®Google Scholar
• Gafane LF, Schutte R, Van Rooyen JM, et al. Plasma renin and cardiovascular responses to the cold pressor test differ in black and white populations: The SABPA study. J Hum Hypertens. 2016;30:346–351.
   PubMed Web of Science ®Google Scholar
• Gafane-Matemane LF, Van Rooyen JM, Schutte R, et al. Aldosterone and renin in relation to surrogate measures of sympathetic activity. Cardiovasc J Afr. 2019;30:34–40.
   Google Scholar
• Nguyen G, Delarue F, Burcklé C, et al. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest. 2002;109:1417–1427.
   PubMed Web of Science ®Google Scholar
• Ellmers LJ, Rademaker MT, Charles CJ, et al. (Pro)renin receptor blockade ameliorates cardiac injury and remodeling and improves function after myocardial infarction. J Card Fail. 2016;22:64–72.
   PubMed Web of Science ®Google Scholar
• Ichihara A, Kaneshiro Y, Takemitsu T, et al. Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension. 2006;47:894–900.
   PubMed Web of Science ®Google Scholar
• Van Vuren EJ, Malan L, von KR, et al. Hyperpulsatile pressure, systemic inflammation and cardiac stress are associated with cardiac wall remodelling in an African male cohort: the SABPA study. Hypertens Res. 2016;39:648–653.
   PubMed Web of Science ®Google Scholar
• Joseph JJ, Echouffo-Tcheugui JB, Kalyani RR, et al. Aldosterone, renin, cardiovascular events, and all-cause mortality among African Americans: the Jackson Heart Study. JACC Heart Fail. 2017;5:642–651.
   PubMed Web of Science ®Google Scholar
• Guyton AC, Coleman TG, Cowley AW, et al. Arterial pressure regulation: overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med. 1972;52:584–594.
   PubMed Web of Science ®Google Scholar
• Ashton AW, Le TY, Gomez-Sanchez CE, et al. Role of nongenomic signaling pathways activated by aldosterone during cardiac reperfusion injury. Mol Endocrinol. 2015;29:1144–1155.
   PubMed Web of Science ®Google Scholar
• Xiao TT, Wang YY, Zhang Y, et al. Similar to spironolactone, oxymatrine is protective in aldosterone-induced cardiomyocyte injury via inhibition of calpain and apoptosis-inducing factor signaling. PLOS One. 2014;9:e88856.
   PubMed Web of Science ®Google Scholar
• deFilippi CR, Christenson RH. B-Type natriuretic peptide (BNP)/NT-proBNP and renal function: is the controversy over? Clin Chem. 2009;55:1347–1353.
   PubMed Web of Science ®Google Scholar
• Katholi RE, Couri DM. Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications. Int J Hypertens. 2011;2011:1.
   Google Scholar
• Sharma S, Jackson PG, Makan J. Cardiac troponins. J Clin Pathol. 2004;57:1025–1026.
   PubMed Web of Science ®Google Scholar